Orbital Therapeutics Appoints Anna Dixon as Senior Vice President
05 Sep 2024 //
BUSINESSWIRE
Orbital Therapeutics Appoints Ron Philip as Chief Executive Officer
03 Sep 2024 //
BUSINESSWIRE
Orbital Therapeutics closes South San Francisco lab, eliminating some roles
13 Nov 2023 //
ENDPTS
Orbital Therapeutics Secures $270 Million in Series A Financing
26 Apr 2023 //
BUSINESSWIRE
Latham & Watkins Advises Orbital Therapeutics Partnership With Beam Therapeutics
27 Oct 2022 //
PRESS RELEASE